Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging-Reference-Cited by-同舟云学术

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Published:2023-11-07 Issue:19 Volume:101 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Pittock Rioghna R.¹^ORCID,Aakre Jeremiah A.¹,Castillo Anna M.¹^ORCID,Ramanan Vijay K.¹^ORCID,Kremers Walter K.¹,Jack Clifford R.¹^ORCID,Vemuri Prashanthi¹,Lowe Val J.¹,Knopman David S.¹,Petersen Ronald C.¹^ORCID,Graff-Radford Jonathan¹,Vassilaki Maria¹^ORCID

Affiliation:

1. From the Department of Neurology (R.R.P., V.K.R., D.S.K., R.C.P., J.G.-R.), Mayo Clinic, Rochester, MN; The College (R.R.P.), University of Chicago, IL; Departments of Quantitative Health Sciences (J.A.A., A.M.C., W.K.K., R.C.P., M.V.) and Radiology (C.R.J., P.V., V.J.L.), Mayo Clinic, Rochester, MN.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207770

Reference46 articles.

1. Alzheimer's disease drug development pipeline: 2022

2. Hodes RJ. NIA statement on report of lecanemab reducing cognitive decline in Alzheimer's clinical trial. Accessed January 10 2023. nia.nih.gov/news/nia-statement-report-lecanemab-reducing-cognitive-decline-alzheimers-clinical-trial

3. Lecanemab in Early Alzheimer’s Disease

4. Lecanemab trial in AD brings hope but requires greater clarity

5. Potential eligibility for Aducanumab therapy in an Irish specialist cognitive service—Utilising cerebrospinal fluid biomarkers and appropriate use criteria

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Centers for Medicare and Medicaid Services Coverage of Amyloid PET;JAMA Neurology;2024-09-01

2. Guardians of memory: The urgency of early dementia screening in an aging society;Intractable & Rare Diseases Research;2024-08-31

3. Spatiotemporal Dysregulation of Neuron–Glia Related Genes and Pro-/Anti-Inflammatory miRNAs in the 5xFAD Mouse Model of Alzheimer’s Disease;International Journal of Molecular Sciences;2024-08-31

4. Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome;Neurology;2024-08-27

5. Digital Clock and Recall: a digital, process-driven evolution of the Mini-Cog;Frontiers in Human Neuroscience;2024-08-26